Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of ALTO-100 in Adults With Major Depressive Disorder and/or Post-traumatic Stress Disorder

NCT05117632 is registered in ClinicalTrials.gov with Alto Neuroscience as lead sponsor.

NCT NCT05117632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05117632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of ALTO-100 in Adults With Major Depressive Disorder and/or Post-traumatic Stress Disorder
Lead sponsor
Alto Neuroscience
Phase
Phase 2
Overall status
Completed
Start date
December 20, 2021
Completion date
December 9, 2022
Enrollment
245 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, post traumatic stress disorder